The results demonstrated that SIRT3 activation effectively attenuates the impairment of osteoblast formation and bone loss in T2DM by revitalizing the PINK1/PRKN-mediated mitophagy. The gene discussed is PINK1; the disease is type 2 diabetes mellitus.